PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31

Pharma-Bio Serv, Inc.

Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026

$0.48+0.08 (+20.00%)

Close on Oct 19, 2026

Community

Notes and questions about Pharma-Bio Serv from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Pharma-Bio Serv's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PBSV.

Revenue growth3.3% · median 2.3%

Gross margin32.3% · median 36.0%

Operating margin-1.6% · median -99.0%

Net margin2.7% · median -105.1%

Advertisement
300 × 250